Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 3, 2023
Patent Application Number
17186137
Date Filed
February 26, 2021
Patent Citations
Patent Primary Examiner
CPC Code
Disclosed herein, in part, are methods of treating neurological disorders, e.g., schizophrenia and major depressive disorder, comprising administering an effective amount of a disclosed heterocyclic compound. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
